📜脱氢枞酸甲酯置于吡啶,4-二甲氨基吡啶,Selenium(Iv) Oxide,Aluminum (Iii) Chloride,Potassium Osmate(Vi) Dihydrate,双[α,α-双(三氟甲基)苯甲醇合]二苯硫,偶氮二异丁腈,Pyridine Hydrofluoride,三氟甲磺酸三甲基硅酯,三正丁基氢锡,Sodium Methylate,甲基(三氟甲基)-1,3-二环氧丙烷,L-Selectride,Potassium Carbonate,对甲苯磺酸,臭氧,N-甲基吗啉氧化物,三乙胺,间氯过氧苯甲酸,三氟乙酸体系中,用 四氢呋喃,1,4-二氧六环,甲醇,氟苯,六氟苯,二氯甲烷,氯仿,水,丙酮,甲苯,乙腈,1,1,2,2-四氯乙烷 作为反应溶剂,化学反应 114.9H,反应生成 印楝素
参考文献: Nimbolide Analogs And Methods Of Use Thereof[fr] Analogues De Nimbolide Et Leurs Méthodes D'Utilisation
标题: Nimbolide Analogs And Methods Of Use Thereof[fr] Analogues De Nimbolide Et Leurs Méthodes D'Utilisation
摘要:Disclosed Herein Are Compounds Of The Formula (I) Or (II) Wherein The Variables Are Defined Herein. Also Provided Are Methods Of Manufacturing And Pharmaceutical Compositions Thereof. In Some Aspects,The Compounds And Compositions Provided Herein May Be Used As Parp1 Inhibitors. In Some Aspects,The Present Disclosure Provides Methods Wherein The Compounds And Compositions Described Herein Are Used For The Treatment Of Diseases And Disorders,Such As Cancer.